Dual-Wavelength Quantitative Fluorescence Endoscopy for Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer: A Phase I Multicenter Feasibility and Safety Study

2024-520090-12-00 Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 1 May 2026 · Status Ongoing, recruiting · 1 EU/EEA countries · 3 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 15
Countries 1
Sites 3

Esophageal cancer

Key facts

Sponsor
Universitair Medisch Centrum Groningen
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Digestive System Diseases [C06], Diseases [C] - Neoplasms [C04]
Trial duration
1 May 2026 → ongoing
Decision date (initial)
2025-06-13
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Esophageal cancer

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Universitair Medisch Centrum Groningen

Sponsor organisation
Universitair Medisch Centrum Groningen
Address
Hanzeplein 1
City
Groningen
Postcode
9713 GZ
Country
Netherlands

Scientific contact point

Organisation
Universitair Medisch Centrum Groningen
Contact name
Wouter Nagengast

Public contact point

Organisation
Universitair Medisch Centrum Groningen
Contact name
Wouter Nagengast

Locations

1 EU/EEA country · 3 investigational sites

By country

CountryMS statusPlanned subjectsSites
Netherlands Ongoing, recruiting 15 3
Rest of world 0

Investigational sites

Netherlands

3 sites · Ongoing, recruiting
Stichting Martini Ziekenhuis
Maag-, darm-, leverziekten, Van Swietenplein 1, 9728 NT, Groningen
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Department Otorhinolaryngology, Head and Neck Surgery, Dr. Molewaterplein 40, 3015 GD, Rotterdam
Universitair Medisch Centrum Groningen
Maag-, darm-, leverziekten, Hanzeplein 1, 9713 GZ, Groningen

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Netherlands 2026-05-01 2026-05-01

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-03-05 Netherlands Acceptable with conditions
2025-06-13
2025-06-13
2 NON SUBSTANTIAL MODIFICATION NSM-1 2025-08-11 Netherlands Acceptable with conditions
2025-06-13
2025-08-11
3 SUBSTANTIAL MODIFICATION SM-2 2026-02-09 Netherlands Acceptable
2026-02-26
2026-02-26